Tert-butyl 4-[5-cyclopentyloxy-1-(3,5-difluorophenyl)-6-oxopyridazin-4-yl]piperazine-1-carboxylate | 1295575-98-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: Tert-butyl 4-[5-cyclopentyloxy-1-(3,5-difluorophenyl)-6-oxopyridazin-4-yl]piperazine-1-carboxylate
• CAS: 1295575-98-2
• 化学式: C₂₄H₃₀F₂N₄O₄
• 分子量: 476.523
• InChiKey: MHYHKCWOLMCGEO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  34
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  74.7
• 氢给体数：
  0
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  Tert-butyl 4-[5-cyclopentyloxy-1-(3,5-difluorophenyl)-6-oxopyridazin-4-yl]piperazine-1-carboxylate 在 盐酸 、 三乙胺 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 生成 4-Cyclopentyloxy-2-(3,5-difluorophenyl)-5-[4-(pyridin-4-ylmethylsulfonyl)piperazin-1-yl]pyridazin-3-one
  参考文献：
  名称：

  The optimization of pyridazinone series of glucan synthase inhibitors

  摘要：

  A detailed structure-activity relationship study of a novel series of pyridazine-based small molecule glucan synthase inhibitors is described. The optimization of the PK profile of this series led to the discovery of compound 11g, which demonstrated in vivo potency ip in a lethal fungal infection model. (c) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.06.091
• 作为产物：
  描述：

  4,5-Dichloro-2-(3,5-difluorophenyl)pyridazin-3-one 在 sodium hexamethyldisilazane 、 三乙胺 作用下， 以 乙醇 为溶剂， 生成 Tert-butyl 4-[5-cyclopentyloxy-1-(3,5-difluorophenyl)-6-oxopyridazin-4-yl]piperazine-1-carboxylate
  参考文献：
  名称：

  The optimization of pyridazinone series of glucan synthase inhibitors

  摘要：

  A detailed structure-activity relationship study of a novel series of pyridazine-based small molecule glucan synthase inhibitors is described. The optimization of the PK profile of this series led to the discovery of compound 11g, which demonstrated in vivo potency ip in a lethal fungal infection model. (c) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.06.091

文献信息

• The synthesis and structure–activity relationship of pyridazinones as glucan synthase inhibitors
  作者：Pauline C. Ting、Rongze Kuang、Heping Wu、Robert G. Aslanian、Jianhua Cao、David W. Kim、Joe F. Lee、John Schwerdt、Gang Zhou、Samuel Wainhaus、Todd A. Black、Anthony Cacciapuoti、Paul M. McNicholas、Yiming Xu、Scott S. Walker

  DOI：10.1016/j.bmcl.2011.01.058

  日期：2011.3

  A structure-activity relationship study of the lead 5-[4-(benzylsulfonyl) piperazin-1-yl]-4-morpholino-2- phenyl-pyridazin-3(2H)-one 1 has resulted in the identification of 2-(3,5-difluorophenyl)-4-(3-fluorocyclopentyloxy)- 5-[4-(isopropylsulfonyl) piperazin-1-yl]-pyridazin-3(2H)-one 11c as a beta- 1,3-glucan synthase inhibitor. Compound 11c exhibited significant efficacy in an in vivo mouse model of Candida glabrata infection. (C) 2011 Elsevier Ltd. All rights reserved.
• The optimization of pyridazinone series of glucan synthase inhibitors
  作者：Rongze Kuang、Heping Wu、Pauline C. Ting、Robert G. Aslanian、Jianhua Cao、David W. Kim、Joe F. Lee、John Schwerdt、Gang Zhou、R. Jason Herr、Andrew J. Zych、Jinhai Yang、Sang Q. Lam、David M. Jenkins、Samuel A. Sakwa、Samuel Wainhaus、Todd A. Black、Anthony Cacciapuoti、Paul M. McNicholas、Yiming Xu、Scott S. Walker

  DOI：10.1016/j.bmcl.2012.06.091

  日期：2012.8

  A detailed structure-activity relationship study of a novel series of pyridazine-based small molecule glucan synthase inhibitors is described. The optimization of the PK profile of this series led to the discovery of compound 11g, which demonstrated in vivo potency ip in a lethal fungal infection model. (c) 2012 Elsevier Ltd. All rights reserved.